Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

NS Pharma announces a leadership change, appointing new commercial head to drive strategic growth and innovation

NS Pharma, Inc. announced a change of leadership within its Commercial division. Effective September 9, 2024, Donald Foy – who had previously served as national sales director – was appointed to the role of vice president, Commercial. Jennifer...

Pharmaceutics and Drug Delivery Systems 2024

is pleased to announce the “International conference on Pharmaceutics and Drug Delivery Systems” to be held on Nov 26-27, 2024 at Dubai, UAE. Genvio Group is pleased to announce the “International conference on Pharmaceutics and Drug Delivery...

A Korea University study identifies mitochondrial dysfunction as a key factor in cognitive and metabolic impairments, offering insights into potential treatments

often nonfunctional protein and effectively causing a loss of function. Their study appeared online on November 01, 2024 in the journal Experimental & Molecular Medicine. Highlighting the significance of this achievement, senior author Prof. Lee...

International Conference on Neuroscience and Neurology 2024

International Conference on Neuroscience and Neurology” in Amsterdam, Netherlands, on November 18-20, 2024. International Conference on Neuroscience and Neurology” in Amsterdam, Netherlands, on November 18-20, 2024. This Neurology conference and...

Axonal.AI launches an industry-first platform to accelerate life sciences time to market

compliant marketing. Axonal.AI was founded by Larry Mickelberg, who was named earlier this year as one of MM+M Magazine’s 2024 Top Healthcare Marketing Influencers. With over 20 years of leadership experience at leading management consultancies and...

Aadi Bioscience reports Q3 2024 financial results and updates on corporate progress

Aadi Bioscience, Inc. announced financial results for the third quarter ended September 30, 2024, and provided recent corporate progress. "The third quarter saw strong sales growth for FYARRO, backed by continued account momentum, increased demand...

HanAll Biopharma releases Q3 2024 financial results and shares business updates

to discovering and developing innovative medicines for patients, reported financial results for the third quarter of 2024 and provided business updates. HanAll ended the third quarter with total revenue of 36.8 billion KRW, reflecting an 11.7%...

2nd International Conference on Biotechnology and Bioengineering 2024

2nd International Conference on Biotechnology and Bioengineering, a Hybrid Event scheduled from October 24-25, 2024, Paris, France. We cordially invite competitors from all corners of the globe to showcase their expertise, talents, and research in...

NanoMedicine International Conference 2024

NanoMedicine 2024 will cover the most recent international developments in the field of Nanobiotechnology and Nanomedicine. Participants will get a complete overview on the state of the art in these fields and on the research carried out and the...

3rd BioPharma 2024

3rd BioPharma Site Solutions Summit the premier event that aims to tackle the critical challenges facing the clinical trial industry. 3rd BioPharma Site Solutions Summit the premier event that aims to tackle the critical challenges facing the...

The U.S. FDA provides positive guidance on the Phase III trial of 64Cu-SAR-bisPSMA for recurrent prostate cancer.

Prostate cancer is the second-leading causes of cancer death in American men. The American Cancer Institute estimates in 2024 there will be 299,310 new cases of prostate cancer in the US and around 35,250 deaths from the disease[2]. About Clarity...

16th Asian Conference on Pharmacoepidemiology 2024

16th Asian Conference on Pharmacoepidemiology (ACPE), scheduled to take place from October 12th to 14th, 2024, in Tokyo, Japan. 16th Asian Conference on Pharmacoepidemiology (ACPE), scheduled to take place from October 12th to 14th, 2024, in...

Eisai strengthens its presence in Saudi Arabia by establishing a new pharmaceutical sales subsidiary to enhance its operations in the region

Eisai Saudi Arabia was established in April 2024 in order to build an in-house sales system. Japan-based Eisai Co. has announced that fully-fledged operations and business activities have begun at Eisai Pharmaceuticals Single Person Limited...

Blue Earth Therapeutics shares positive Phase 1 results for Lutetium (177Lu) rhPSMA-10.1 Injection, advancing its clinical development

in Patients with Prostate Cancer: A Comprehensive Systematic Review and Meta analysis." Journal of Nuclear Medicine (2024). About Radiohybrid Prostate‐Specific Membrane Antigen (rhPSMA): rhPSMA compounds are referred to as radiohybrid ("rh"), as...

Disruptive Technology for Clinical Trials Summit 2024

With the global clinical trial management system market projected to rise to $2.72 billion by 2028, the pharma industry is witnessing a significant shift towards embracing technology-driven solutions to enhance efficiency, streamline processes,...

Promega introduces the GloMax® Galaxy Bioluminescence Imager to illuminate protein dynamics in real time

scientific challenges, enabling researchers to make meaningful advances in their fields. Promega invites attendees of SFN 2024 to Booth #1316 to experience live demonstrations of the Glomax® Galaxy, showcasing its potential to transform research....

Drug Discovery 2024

ELRIG aims to remove as many barriers to conference attendance as possible, so all events are free to attend and with a prayer room, family room and quiet room available, ensuring our promise of inclusivity is at the heart of all our events....

Fierce Clinical Summit 2024

The Fierce Clinical Summit 2024 is the flagship event for clinical research and trial management professionals. The Fierce Clinical Summit 2024 is the flagship event for clinical research and trial management professionals. This year’s program...

nuBioAge, nuHx, and Marius Pharmaceuticals launch a collaborative GLP-1 comparison study in male patients.

weight loss but also maintain the strength and energy they need for a healthy life." The study is set to start December 2024 at the nuHx headquarters in West Palm Beach and conclude May 2025 with published study results to follow. nuBioAge and its...

Anixa Biosciences has unveiled its Phase 2 study plan for a breast cancer vaccine.

the Phase 1 trial will be presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting in early November 2024. The Phase 1 trial is conducted in collaboration with Cleveland Clinic and is funded by a grant from the U.S. Department of...

Results 61 - 80 of 130